Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07567040 · ClinicalTrials.gov registry record · Phase 3
Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial
A Phase 3 study, sponsored by Ohio State University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 664
- Enrollment target
NCT07567040 is a Phase 3 study that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 664 participants.
The verdict
NCT07567040, a Phase 3 study, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 664 participants
- Enrollment target
Study Summary
The aims of this clinical trial will test whether or not the onset of nearsightedness is delayed in a group of children randomized to nightly drops in 0.05% atropine in both eyes, in comparison to children who receiving nightly placebo drops in both eyes. The primary outcome is the two-year cumulative incidence of nearsightedness. The second aim of this project will determine whether atropine is associated with slower eye growth in children receiving nightly drops of atropine versus placebo.
Interventions
- DRUG Placebo
- DRUG Atropine Sulfate 0.05% Oph Soln
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 664 participants |
| Start Date | 2026-05-27 |
| Est. Completion | 2028-05-15 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07567040
The ClinicalTrials.gov registry entry for NCT07567040 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 664 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07567040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07567040 about?
NCT07567040 is a clinical study titled "Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial". The aims of this clinical trial will test whether or not the onset of nearsightedness is delayed in a group of children randomized to nightly drops in 0.05% atropine in both eyes, in comparison to children who receiving nightly placebo drops in both eyes. The primary outcome is the two-year cumulati...
What is the current status of trial NCT07567040?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 664 participants. The study started on 2026-05-27. Estimated completion is 2028-05-15.
What interventions are being tested in trial NCT07567040?
The interventions under investigation include: Placebo (DRUG), Atropine Sulfate 0.05% Oph Soln (DRUG).
Who is sponsoring clinical trial NCT07567040?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.